2004
DOI: 10.1136/jcp.57.1.6
|View full text |Cite
|
Sign up to set email alerts
|

The eicosanoid cascade: possible role in gliomas and meningiomas

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2

Citation Types

2
49
0
7

Year Published

2004
2004
2011
2011

Publication Types

Select...
5
2
2

Relationship

0
9

Authors

Journals

citations
Cited by 88 publications
(58 citation statements)
references
References 98 publications
2
49
0
7
Order By: Relevance
“…Inhibition of each one of them raises intracellular ARA levels, although combined inhibition could provide the most profound results [10]. Corticosteroids prevent the release of ARA from cancer cells via inhibition of cytosolic phospholipase A2 (cPLA2), an action which results in less available proinflammatory mediators, but also in less intracellular ARA.…”
Section: Discussionmentioning
confidence: 99%
“…Inhibition of each one of them raises intracellular ARA levels, although combined inhibition could provide the most profound results [10]. Corticosteroids prevent the release of ARA from cancer cells via inhibition of cytosolic phospholipase A2 (cPLA2), an action which results in less available proinflammatory mediators, but also in less intracellular ARA.…”
Section: Discussionmentioning
confidence: 99%
“…13 Recently, gliomas and meningiomas were also found to overexpress both COX and LO enzymes compared with normal brain tissue. 6,8,37 Matsuo and coworkers 32 reported that the staining intensity in glioblastomas was relatively weak, but that meningiomas and WHO Grade II/III astrocytomas were strongly positive for COX-2. Although much attention has been focused on the role of COX-derived metabolites in cancer development and progression, accumulating evidence suggests that 5-LO-derived eicosanoids may play an equally important role.…”
mentioning
confidence: 99%
“…Os fosfolipídios de membrana são clivados por duas vias enzimáticas distintas: a da cicloxigenase, gerando as prostaglandinas (PGD) e as tromboxanas (TBX), e a da lipoxigenase, gerando os leucotrienos (LCT) e as lipoxinas. Os eicosanoides participam na modulação da motilidade e adesão celular, aumentam a permeabilidade vascular e medeiam diversos processos na inflamação (NATHOO et al, 2004). Recentes estudos mostram que o tratamento de monócitos humanos com PGE 2 afeta a expressão de receptores para quimiocinas e modula a responsividade destas células à ação quimiotática, diminuindo a expressão do receptor para MIP-1α e MIP-1β (CCR5), porém não interferindo na expressão dos receptores CCR2 ou CXCR4, importantes na quimiotaxia de monócitos em resposta as quimiocinas MCP-1 e RANTES (PANZER et al, 2004).…”
Section: Discussionunclassified